{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:01:53Z","timestamp":1784671313716,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["BCG_FF_69_111_2300_029"],"award-info":[{"award-number":["BCG_FF_69_111_2300_029"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejmech.2026.118732","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:18:27Z","timestamp":1772558307000},"page":"118732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phenoxy-linked colchicine derivatives: A structure-based approach toward enhanced selectivity and \u03b1-tubulin interaction"],"prefix":"10.1016","volume":"309","author":[{"given":"Gbenga","family":"Olorunmodimu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Vrubliauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jantana","family":"Yahuafai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangjai","family":"Todsaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borwornlak","family":"Toopradab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phornphimon","family":"Maitarad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyada","family":"Rungrotmongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanat","family":"Aonbangkhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7236-0625","authenticated-orcid":false,"given":"Tanatorn","family":"Khotavivattana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118732_bib1","first-page":"1","article-title":"Cancer: an overview","volume":"8","author":"Mathur","year":"2015","journal-title":"Acad. J. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118732_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/ph14090835","article-title":"Challenges of current anticancer treatment approaches with focus on liposomal drug delivery systems","volume":"14","author":"Gyanani","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118732_bib3","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1586\/14737140.6.10.1433","article-title":"Drug target interaction of tubulin-binding drugs in cancer therapy","volume":"6","author":"Sengupta","year":"2006","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.ejmech.2026.118732_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/80.1.14","article-title":"Multidrug resistance","volume":"80","author":"Moscow","year":"1988","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2026.118732_bib5","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1021\/bi001372n","article-title":"P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation","volume":"40","author":"Druley","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.118732_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118732_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejmech.2015.03.035","article-title":"Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors","volume":"95","author":"Zhang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1007762","article-title":"Editorial: cancer therapy: the challenge of handling a double-edged sword","volume":"13","author":"Nurgali","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118732_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.640863","article-title":"The role of microtubules in pancreatic cancer: therapeutic progress","volume":"11","author":"Albahde","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.118732_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-319-57127-0_5","article-title":"The elephant in the room; the role of microtubules in cancer","volume":"1002","author":"Cirrilo","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2026.118732_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/cells7110192","article-title":"Antiproliferative activity and molecular docking of novel double-modifed colchicine derivatives","volume":"7","author":"Majcher","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.118732_bib12","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.3390\/cancers14184368","article-title":"Microtubule dynamics and cancer","volume":"14","author":"Ritter","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.118732_bib13","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.21037\/tcr-20-682","article-title":"A review of research progress of antitumor drugs based on tubulin targets","volume":"9","author":"Cheng","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118732_bib14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1139\/cjc-2012-0360","article-title":"Interactions of laulimalide, peloruside, and their derivatives with the isoforms of \u03b2-tubulin","volume":"91","author":"Gajewski","year":"2013","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/cm.20436","article-title":"Tumoral and tissue-specific expression of the major human \u03b2-tubulin isotypes","volume":"67","author":"Leandro-Garc\u00eda","year":"2010","journal-title":"Cytoskeleton"},{"key":"10.1016\/j.ejmech.2026.118732_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1476-4598-9-131","article-title":"Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives","volume":"9","author":"Tseng","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.118732_bib17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2174\/156800907783220453","article-title":"Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?","volume":"7","author":"Ferlini","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2026.118732_bib18","doi-asserted-by":"crossref","first-page":"12902","DOI":"10.1074\/jbc.M414477200","article-title":"\u03b2III-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability","volume":"280","author":"Kamath","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib19","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1158\/1535-7163.MCT-05-0244","article-title":"Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel","volume":"4","author":"Seve","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2026.118732_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.841777","article-title":"Recent approaches to the identification of novel microtubule-targeting agents","volume":"9","author":"Eli","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2026.118732_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107076","article-title":"Tubulin inhibitors. Selected scaffolds and main trends in the design of novel anticancer and antiparasitic agents","volume":"143","author":"Podolak","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1021\/np800568j","article-title":"Tubulin-interactive natural products as anticancer agents","volume":"72","author":"Kingston","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.118732_bib23","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.3390\/molecules25245986","article-title":"A compressive review about taxol\u00ae: history and future challenges","volume":"25","author":"Gallego-Jara","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118732_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12935-022-02624-9","article-title":"Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine","volume":"22","author":"Dhyani","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2026.118732_bib25","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1021\/acs.biochem.5b00745","article-title":"Effects of eribulin on microtubule binding and dynamic instability are strengthened in the absence of the \u03b2III tubulin isotype","volume":"54","author":"Wilson","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.118732_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1535-7163.MCT-13-0791","article-title":"Targeting microtubules by natural agents for cancer therapy","volume":"13","author":"Mukhtar","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2026.118732_bib27","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1021\/acs.jmedchem.7b00717","article-title":"Beyond the rule of 5: lessons learned from AbbVie's drugs and compound collection miniperspective","volume":"61","author":"DeGoey","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2021.10.002","article-title":"Colchicine\u2013new horizons for an ancient drug. Review based on the highest hierarchy of evidence","volume":"96","author":"Schattner","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ejmech.2026.118732_bib29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118732_bib30","doi-asserted-by":"crossref","first-page":"13775","DOI":"10.1073\/pnas.0904223106","article-title":"Variations in the colchicine-binding domain provide insight into the structural switch of tubulin","volume":"106","author":"Dorleans","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.118732_bib31","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejmech.2026.118732_bib32","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1021\/acs.joc.5c00284","article-title":"Deconstruction of desacetamidocolchicine's B ring reveals a class 3 atropisomeric AC ring with tubulin binding properties","volume":"90","author":"Bejcek","year":"2025","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib33","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.bmcl.2011.04.014","article-title":"Synthesis and characterization of a novel tubulin-directed DO3A-colchicine with potential theranostic features","volume":"21","author":"Wardle","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118732_bib34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejmech.2016.11.049","article-title":"Interactions of long-chain homologues of colchicine with tubulin","volume":"126","author":"Marzo-Mas","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejmech.2018.03.019","article-title":"Effects on tubulin polymerization and down-regulation of c-Myc, hTERT and VEGF genes by colchicine haloacetyl and haloaroyl derivatives","volume":"150","author":"Marzo-Mas","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fchem.2020.00108","article-title":"In silico investigations of the mode of action of novel colchicine derivatives targeting \u03b2-tubulin isotypes: a search for a selective and specific \u03b2-III tubulin ligand","volume":"8","author":"Pallante","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib37","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.bmcl.2006.02.010","article-title":"Synthesis and biological evaluation of B-ring modified colchicine and isocolchicine analogs","volume":"16","author":"Cifuentes","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118732_bib38","article-title":"Recent developments on (\u2212)-colchicine derivatives: synthesis and structure-activity relationship","volume":"185","author":"Ghawanmeh","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib39","doi-asserted-by":"crossref","first-page":"26583","DOI":"10.1021\/acsomega.1c03948","article-title":"Novel double-modified colchicine derivatives bearing 1,2,3-triazole: design, synthesis, and biological activity evaluation","volume":"6","author":"Krzywik","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.118732_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128197","article-title":"Synthesis and antiproliferative screening of doubly modified colchicines containing urea, thiourea and guanidine moieties","volume":"47","author":"Krzywik","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118732_bib41","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.3390\/molecules25153540","article-title":"New series of double-modified colchicine derivatives: synthesis, cytotoxic effect and molecular docking","volume":"25","author":"Krzywik","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118732_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/med.20097","article-title":"Anti\u2010mitotic activity of colchicine and the structural basis for its interaction with tubulin","volume":"28","author":"Bhattacharyya","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.118732_bib43","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1016\/j.bmcl.2009.05.054","article-title":"Design, synthesis and identification of novel colchicine-derived immunosuppressant","volume":"19","author":"Chang","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118732_bib44","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/S0021-9258(18)83481-0","article-title":"The binding of isocolchicine to tubulin. Mechanisms of ligand association with tubulin","volume":"264","author":"Hastie","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118732_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119527","article-title":"A comprehensive review on time-tested anticancer drug doxorubicin","volume":"278","author":"Sritharan","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2026.118732_bib46","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.ejmech.2026.118732_bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118732_bib48","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1021\/ci500081m","article-title":"Comparative assessment of scoring functions on an updated benchmark: 2. Evaluation methods and general results","volume":"54","author":"Li","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118732_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1874104501913010040","article-title":"Evaluation of scoring function performance on DNA-ligand complexes","volume":"13","author":"Fong","year":"2019","journal-title":"Open J. Med. Chem."},{"issue":"50","key":"10.1016\/j.ejmech.2026.118732_bib52","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1016\/j.tetlet.2014.10.069","article-title":"Microwave-assisted synthesis and click chemistry as simple and efficient strategy for RGD functionalized hydrogels","volume":"55","author":"Sacchetti","year":"2014","journal-title":"Tet. Lett."},{"key":"10.1016\/j.ejmech.2026.118732_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/ol5031469","article-title":"The cyclopentyl group, as a small but bulky terminal group, allows rapid and efficient active transport","volume":"17","author":"Nishiyama","year":"2015","journal-title":"Org. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:18:16Z","timestamp":1784668696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426001777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":51,"alternative-id":["S0223523426001777"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118732","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenoxy-linked colchicine derivatives: A structure-based approach toward enhanced selectivity and \u03b1-tubulin interaction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118732"}}